HOUSTON--(BUSINESS WIRE)--Proxima Clinical Research (“Proxima CRO”), a company guiding emerging medical device and pharmaceutical companies from the earliest stages of product development through commercialization, announced today it has been named to the Inc. Regionals 2022 Southwest list of the Fastest-Growing Private Companies and was recently recognized by the Houston Business Journal as a company to watch, as noted in its inaugural Houston Inno Fire Awards.
Inc. 5000 represents nearly 40 years of exceptional American growth stories where entrepreneurs have remained the key benchmark for success. The Regionals recognizes fast growing companies in various regions across the nation with Proxima CRO receiving honors in the Southwest.
Houston Inno Fire Awards finalist list recognizes 25 Houston-area companies that had breakout years in 2021. Selections are based largely on major milestones, including overall growth, innovative ways of doing things, funding rounds, product launches, and social impact. Proxima Clinical Research is honored to be listed among is neighbors from across Houston and the surrounding areas. From energy technology companies to pharmaceutical development and life sciences, all the way to innovative local nonprofit organizations, the finalists for Houston Inno's Fire Awards are pushing the bar to new heights in the Bayou City.
“Our growth is a direct reflection of the quality of our team and the people that work here,” says Kevin Coker, CEO. “The recognition and accolades we are receiving from reputable organizations like Inc. and Houston Business Journal, among the many others, is further proof we are on the right track and serving clients in the right ways.”
Proxima CRO is proud to join companies such as Microsoft, Under Armour, Facebook and Chobani as past Inc. 5000 Regionals award winners, as these companies have gone on to become business icons; and the company is proud to top the list at Houston Inno Fire Awards among many of the incredible emerging companies in Houston such as Volumetric, Velentium, Saranas, and Houston Methodist to name a few.
About Proxima Clinical Research
Proxima CRO provides regulatory, quality, and clinical research expertise to life sciences companies of all sizes and stages, including inventors, emerging companies, and Fortune 500. With headquarters in the Texas Medical Center (“TMC”), the largest medical center in the world, Proxima CRO brings its expertise to hundreds of medical device, pharmaceutical, biotechnology, and diagnostic companies in 17 countries across five continents to further advance the $130 billion industry. Launched in November 2017, Proxima CRO is a registered Delaware C Corporation. For more on Proxima CRO and its growing team, visit ProximaCRO.com.
